Eton Pharmaceuticals, Inc. (ETON) Financials

ETON Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 115.8 million 69.2 million
March 31, 2026 97.7 million 67.1 million
Dec. 31, 2025 92.1 million 66.0 million
Sept. 30, 2025 104.5 million 81.4 million

ETON Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 7.3 million 1.5 million
March 31, 2026 7.3 million 1.5 million
Dec. 31, 2025 -11.6 million 1.1 million
Sept. 30, 2025 11.7 million 1.1 million

ETON Net Income

No data available :(

ETON Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 26.8 million 19.1 million 1.1 million
March 31, 2026 19.7 million 440000 440000
Dec. 31, 2025 25.9 million 460000 460000
Sept. 30, 2025 37.1 million 480000 480000

ETON Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 32.8 million
March 31, 2026 31.5 million
Dec. 31, 2025 26.9 million
Sept. 30, 2025 26.9 million

ETON Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5000 993000 11.6 million -
March 31, 2026 75000 1.9 million 10.4 million -
Dec. 31, 2025 49000 1.8 million 8.9 million -
Sept. 30, 2025 284000 1.1 million 8.1 million -

ETON Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 37.6 million 12.2 million
March 31, 2026 24.3 million 9.5 million
Dec. 31, 2025 21.3 million 8.2 million
Sept. 30, 2025 22.5 million 14.6 million

ETON Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ETON

Price: $51.33

52 week price:
14.27
66.37

Payout Ratio Range:
-28.10%
-14.68%

Earnings Per Share: 0.39 USD

P/E Ratio: 157.64

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 36257

Market Capitalization: 1.5 billion

Links: